<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308096">
  <stage>Registered</stage>
  <submitdate>19/06/2009</submitdate>
  <approvaldate>29/06/2009</approvaldate>
  <actrnumber>ACTRN12609000514202</actrnumber>
  <trial_identification>
    <studytitle>Prospective clinical study using X-ray to evaluate fixation of cementless total knee replacement components</studytitle>
    <scientifictitle>In patients with osteoarthritis of the knee, do cementless total knee replacement components, comparing radiographic micromotion at 6 months and 2 years, provide adequate long-term fixation at the implant-bone interface.</scientifictitle>
    <utrn>U1111-1129-8733</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Osteoarthritis of the knee</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Total knee arthroplasty will be performed using a traditional medial parapatellar approach. Distal femur and proximal tibia resections will be completed using intramedullary alignments jigs. Implantation of the femoral and tibial tray components will be performed without the use of bone cement. The approximate duration of the procedure is 90-120 minutes. Micromotion of the implanted components will be assessed by X-ray, using the pre-weight-bearing position as the base for subsequent measurements.</interventions>
    <comparator>Not a controlled study.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Radiographic micromotion, consisting of component migration and rotation relative to the proximal tibia and distal femur.</outcome>
      <timepoint>Post-op before weight-bearing; 6 weeks post-op; 3 months post-op; 6 months post-op; 1 year post-op; 2 years post-op</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Knee function assessed before and after surgery using International Knee Society Score (IKSS), SF-36, Western Ontario and McMaster Universities Questionnaire(WOMAC), Oxford Knee Score, Self-Administrered Comorbidity Questionnaire, Patient Catastrophising Scale, University of California Los Angeles (UCLA) Activity Level Scale.</outcome>
      <timepoint>Pre-op, 6 weeks post-op; 3 months post-op; 6 months post-op; 1 year post-op; 2 years post-op</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Knee function using Walkabout Portable Gait Monitor.</outcome>
      <timepoint>Pre-op, 12 months post-op</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Symptomatic osteoarthritis of the knee requiring intervention.
2. Between the ages of 21 and 80 years inclusive.
3. Ability to give informed consent.</inclusivecriteria>
    <inclusiveminage>21</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Significant co-morbidity affecting ability to ambulate
2. Flexion contracture greater than 15 degrees
3. Extension lag greater than 10 degrees
4. Tibial subluxation greater than 10mm on standing radiograph
5. Prior arthroplasty, patellectomy or osteotomy with the affected knee
6. Lateral or medial collateral ligament instability (&gt;10 degrees varus/valgus)
7. Leg length discrepancy greater than 10mm
8. Active or prior infection
9. Morbid obesity (Body Mass Index, BMI &gt; 40)
10. Medical condition precluding major surgery
11. Severe osteoporosis or osteopenia
12 Neuromuscular impairment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Not applicable.</concealment>
    <sequence>Not applicable.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>6/07/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Stryker Australia</primarysponsorname>
    <primarysponsoraddress>8 Herbert Street
St Leonards
NSW 2065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Stryker Orthopaedics</fundingname>
      <fundingaddress>325 Corporate Drive
Mahwah, NJ  07430</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study assesses the clinical performance of implants used to treat osteoarthritis using total knee replacement. Highly-accurate X-rays will be used to measure any small motions of the implant components at regular intervals after the knee replacement operation. The health status of patients and ability for them to perform activities of daily living will also be measured. This information will be used to confirm that new methods of securing the knee replacement components to the bone are clinically effective.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St John of God Health Care Ethics Committee</ethicname>
      <ethicaddress>Level 3 St John of God House
117-179 Cambridge Street
Subiaco WA 6008</ethicaddress>
      <ethicapprovaldate>26/10/2007</ethicapprovaldate>
      <hrec>No. 293</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Timothy Barker</name>
      <address>Director of Clinical Research
Stryker Australia
8 Herbert Street
St Leonards NSW 2065</address>
      <phone>+61 7 3840 5254</phone>
      <fax>+61 7 3844 8688</fax>
      <email>tim.barker@stryker.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Timothy Barker</name>
      <address>Director of Clinical Research
Stryker Australia
8 Herbert Street
St Leonards NSW 2065</address>
      <phone>+61 7 3840 5200</phone>
      <fax>+61 7 3844 8688</fax>
      <email>tim.barker@stryker.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Timothy Barker</name>
      <address>Director of Clinical Research
Stryker Australia
8 Herbert Street
St Leonards NSW 2065</address>
      <phone>+61 7 3840 5254</phone>
      <fax>+61 7 3844 8688</fax>
      <email>tim.barker@stryker.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>